CDKN2B
viability 0.46 is under the 0.55 bar
Genetics0.36
Brain cell0.35
Druggability0.30
Trial record1.00
Novelty0.74
Pathways0.20
viability · bar 0.550.46
Would flip the verdict
- enrichment in a brain cell type we can culture
- a Reactome pathway tied to known Alzheimer's biology
- a druggable pocket, ligand or antibody route
11 Oct, 17:18 UTC